O8.02 MONITORING OF TREATMENT RESPONSE IN IDH-MUTANT GLIOMAS WITH IN-VIVO 3D MAGNETIC RESONANCE SPECTROSCOPY

The hallmark metabolic alteration in mutant IDH gliomas is the production of R-2-hydroxyglutarate (2HG). 2HG can be measured in-vivo by magnetic resonance spectroscopy of patients, representing an ideal biomarker for IDH mutant gliomas. 3D mapping of 2HG and other metabolites is important to capture...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Cahill, D.P., Loebel, F., Bogner, W., Marjanska, M., Gerstner, E., Batchelor, T., Rosen, B.R., Chi, A., Andronesi, O.C.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2014
Pynciau:
Oral Presentations
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185832/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.63
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg